Brucellosis - A review;Brucelose

Acta Medica Portuguesa

Volumn 12, Issue 12, 1999, Pages 323-330

  Aleixo, Maria João ^a   Ferreira, Maria Leonor ^a   Antunes, Francisco ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; COTRIMOXAZOLE; DOXYCYCLINE; LEVAMISOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; BRUCELLA MELITENSIS; BRUCELLOSIS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; HUMAN; IMMUNOPATHOGENESIS; INFECTION PREVENTION; INFECTION RATE; MALTA; REVIEW; ZOONOSIS;

BRUCELLOSIS; HUMANS;

EID: 0033360981     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. YOUNG EJ: Brucella species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995; 2053-60.
2. CORBEL MJ: National Institute for Biological Standards and Control. Brucellosis: an Overview. Emerging Infectious Diseases 1997; 3 (2): 213-21.
3. CLOECKAERT A, VERGER JM, GRAYON M, VIZCAINO N: Molecular and immunological characterization of the major outer membrane proteins of Brucella. FEMS Microbiol Lett (Netherlands) 1996; 145 (1): 1-8.
4. GOLDBAUM FA, LEONI J, WALLACH JC, FOSSATI CA: Characterization of an 18-Kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. J Clin Microbiol 1993; 31 (8): 2141-45.
5. CLOECKAERT A, DEBBARH HS, VIZCAINO N, SAMAN E, DUBRAY G, ZYGMUNT MS: Cloning, nucleotide sequence, and expression of the Brucella melitensis bp26 gene coding for a protein immunogenic in infected sheep. FEMS Microbiol Lett 1996; 140 (2-3): 139-44.
6. ROSSETTI OL, ARESE AI, BOSCHIROLI ML, CRAVERO SL: Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis. J Clin Microbiol 1996; 34(1): 165-9.
7. HEMMEN F, WEYNANTS V, SCARCEZ T, LETESSON JJ, SAMAN E: Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes. Clin Diagn Lab Immunol 1995; 2 (3): 263-7.
8. CLOECKAERT A, DEBBARH HS, ZYGMUNT MS, DUBRAY G: Production and characterization of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody response of infected sheep from Rev.1 vaccinated sheep. J Med Microbiol 1996; 45 (3): 206-13.
9. LINDLER LE, HADFIELD TL, TALL BD, SNELLINGS NJ, RUBIN FA, VAN DE VERG LL, HOOVER D, WARREN RL: Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis. Infect Immun 1996; 64 (7): 2490-9.
10. BACHRACH G, BANAI M, BARDENSTEIN S, HOIDA G, GENIZI A, BERCOVIER H: Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in Brucella-sensitized Guinea pigs. Infect Immun 1994; 62 (12): 5361-6.
11. LOCKSLEY RM, WILSON CB: Cell-mediated immunity and its role in host defense. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995; 102-49.
12. ZHAN Y, LIU Z, CHEERS C: Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun 1996; 64 (7): 2782-6.
13. ZAITSEVA MB, GOLDING H, BETTS M, YAMAUCHI A, BLOOM ET, BUTLER LE, STEVAN L, GOLDING B: Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus. Infect Immun 1995; 63 (7): 2720-8.
14. ZHAN Y, YANG J, CHEERS C: Cytokine response of T cell subsets from Brucella abortus infected mice to soluble Brucella proteins. Infect Immun 1993; 61 (7): 2841-7.
15. OLIVEIRA SC, HARMS JS, BANAI M, SPLITTER GA: Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs. Cell Immunol 1996; 172 (2): 262-8.
16. ZHAN Y, KELSO A, CHEERS C et al: Cytokine production in the murine response to Brucella infection or immunization with antigenic extracts. Immunology 1993; 80: 458-64.
17. FERNANDEZ-LAGO L, MONTE M, CHORDI A: Endogenous gamma interferon and interleukin-10 in Brucella abortus 2308 infection in mice. FEMS Immunol Med Microbiol 1996; 15 (2-3): 109-14.
18. ZHAN Y, CHEERS C: Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect Immun 1993; 61 (11): 4899-901.
19. JIANG X, BALDWIN CL: Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun 1993; 61 (1): 124-34.
20. OLIVEIRA SC, SPLITTER GA.: CD8+ type 1 CD44hi CD45 RB1o T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I and class II-deficient mice. Eur J Immunol 1995; 25 (9): 2551-7.
21. SPLITTER G, OLIVEIRA S, CAREY M, MILLER C, KO J, COVERT J: T lymphocyte mediated protection against facultative intracellular bacteria. Vet Immunopathol 1996; 54 (1-4): 309-19.
22. BALDWIN CL, WINTER AJ: Macrophages and Brucella. Immunol Ser 1994; 60: 363-80.
23. RODRIGUEZ-ZAPATA M, ALVAREZ-MON M, SALMERON I, PRIETO A, MANZANO L, SALMERON OJ, CARBALLIDO J: Diminished T lymphocyte proliferative response to polyclonal mitogens in acute brucellosis patients. Infection 1996; 24 (2): 115-20.
24. RODRIGUEZ-ZAPATA M, SALMERON I, MANZANO L, SALMERON OJ, PRIETO A, ALVAREZ-MON M: Defective interferon-gamma production by T lymphocytes from patients with acute brucellosis. Eur J Clin Invest 1996; 26 (2): 136-40.
25. SALMERON I, RODRIGUEZ-ZAPATA M, SALMERON O, MANZANO L, VAQUER S, ALVAREZ-MON M: Impaired activity of Natural Killer cells in patients with acute brucellosis. Clin Infect Dis 1992; 15: 764-70.
26. BERTOTTO A, GERLI R, SPINOZZI F, MUSCAT C, SCALISE F, CASTELLUCI G, SPOSITO M, CANDIO F, VACCARO R: Lymphocytes bearing the gd T cell receptor in acute Brucella melitensis infection. Eur J Immunol 1993; 23: 1177-80.
27. LIAUTARD JP, GROSS A, DORNAND J, KOHLER S: Interactions between professional phagocytes and Brucella spp. Microbiologia 1996; 12(2): 197-206.
28. RAFIE-KOLPIN M, ESSENBERG RC: Wyckoff JH 3rd. Identification and comparison of macrophage-induced proteins and proteins induced under various stress conditions in Brucella abortus. Infect Immun 1996; 64 (12): 5274-83.
29. ELZER PH, PHILLIPS RW, ROBERTSON GT, ROOP RM: The HtrA stress response protease contributes to resistance of Brucella abortus to killing by murine phagocytes. Infect Immun 1996; 64 (11): 4838-41.
30. OCON P, REGUERA JM, MORATA P, JUAREZ C, ALONSO A, COLMENERO JD: Phagocytic cell function in active brucellosis. Infect Immun 1994; 62 (3): 910-14.
31. ELZER PH, JACOBSON RH, JONES SM, NIELSEN KH, DOUGLAS JT, WINTER AJ: Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology 1994; 82 (4): 651-8.
32. JANBON F: Brucellose. Encycl Méd-Chir (Paris-France), Maladies Infectieuses, 1993; 8- 038-A-10.
33. REIS P, COELHO P, LEANDRO MJ, FERREIRA ML, AGUAS MJ, BERNARDO L, COSTA ML, CABRAL T, PROENÇA AP, VIANA QUEIROZ M: Manifestações Osteo-articulares na Brucelose Humana: estudo prospectivo em 60 doentes. Rev Port Reumatologia 1994; 45:1057-75.
34. COLMENERO JD, REGUERA JM, MARTOS F, SANCHEZ-DEMORA D, DELGADO M, CAUSSE M, MARTIN-FARFAN A, JUAREZ C: Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine-Baltimore 1996; 75 (4): 195-211.
35. FERREIRA ML, BERNARDO L, BOTAS J, LOBO O: O Líquido Cefalorraquidiano na Brucelose. Revista Portuguesa de Doenças Infecciosas 1989; 12(3): 163-7.
36. ARIZA J, CORREDOIRA J, PALLARES R, VILADRICH PF, RUFIG, PUJOL M, GUDIOL F: Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis 1995; 20 (5): 1241-9.
37. NAVARRO JM, MENDOZA J, LEIVA J, RODRIGUEZ-CONTRERAS R, DE-LA-ROSA M: C-reactive protein as a prognostic indicator in acute brucellosis. Diagn Microbiol Infect Dis 1990; 13 (3): 269-70.
38. DOROANA M, FERREIRA L, TAVARES L, FELICIANO H, BOTAS J: Brucelose: avaliação dos métodos de diagnóstico. Revista Portuguesa de Doenças Infecciosas 1989; 12 (1): 35-9.
39. GAVIRIA-RUIZ MM, CARDONA-CASTRO NM: Evaluation and comparison of different blood culture techniques for bacteriological isolation of Salmonella typhi and Brucella abortus. J Clin Microbiol 1995; 33 (4): 868-71.
40. NAVAS E, GUERRERO A, COBO J, LOZA E: Faster isolation of Brucella spp. from blood by Isolator compared with BACTEC NR. Diagn Microbiol Infect Dis 1993; 16 (1): 79-81.
41. BAUM M, ZAMIR O, BERGMAN-RIOS R, KATZ E, BEIDER Z, COHEN A, BANAI M: Comparative evaluation of microagglutination test and serum agglutination test as supplementary diagnostic methods for brucellosis. J Clin Microbiol 1995; 33 (8): 2166-70.
42. DIAZ-APARICIO E, MARIN C, ALONSO-URMENETA B, ARAGON V, PEREZ-ORTIZ S, PARDO M, BLASCO JM, DIAZ R, MORIYON I: Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats. J Clin Microbiol 1994; 32 (5): 1159-65.
43. ARAJ GF, LULU AR, MUSTAFA MY, KHATEEB MI: Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. J Hyg Lond 1986; 97 (3): 457-69.
44. ARIZA J, PELLICER T, PALLARES R, FOZ A, GUDIOL F: Specific antibody profile in human brucellosis. Clin Infect Dis 1992; 14 (1): 131-40.
45. BALDI PC, MIGUEL SE, FOSSATI CA, WALLACH JC: Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species. Clin Infect Dis 1996; 22 (3): 446-55.
46. MARTIN-MORENO S, GUINEA-ESQUERDO L, CARRERO-GONZALEZ P, VISEDO-ORDEN R, GARCIA-CRBAJOSA S, CALVO-DEL-OLMO T, REVERTE-CEJUDO D: Brucellosis after treatment: the diagnosis of recurrences. Med Clin Barc 1992; 99 (1): 13-6.
47. ROMERO C, GAMAZO C, PARDO M, LOPEZ-GONI I: Specific detection of Brucella DNA by PCR. J Clin Microbiol 1995; 33 (3): 615-7.
48. MATAR GM, KHNEISSER IA, ABDELNOOR AM: Rapid laboratory confirmation of human brucellosis by PCR analysis of a target sequence on the 31-kilodalton Brucella antigen DNA. J Clin Microbiol 1996; 34 (2): 477-8.
49. CLOECKAERT A, VERGER JM, GRAYON M, GREPINET O: Polymorphism at the dnaK locus of Brucella species and identification of a Brucella melitensis species-specific marker. J Med Microbiol 1996; 45 (3): 200-5.
50. LEIVA-LEON J, DE-LA-ROSA M, PLATA J, MARTINEZ MJ, JIMENEZ-ALONSO J: An immunoblotting study of serologic response in patients with acute brucellosis. Diagn Microbiol Infect Dis 1991; 14 (6): 515-8.
51. SOLERA J, MARTINEZ-ALFARO E, ESPINOSA A: Recognition and Optimum Treatment of Brucellosis. Drugs 1997; 53 (2): 245-56.
52. SOLERA J, ESPINOSA A, MARTINEZ-ALFARO E, SANCHEZ L, GEIJO P, NAVARRO E, ESCRIBANO J, FERNANDEZ JA: Treatment of human brucellosis with doxycycline and gentamicin. Antimicrob Agents Chemother 1997; 41 (1): 80-4.
53. SOLERA J, ESPINOSA A, GEIJO P, MARTINEZ-ALFARO E, SAEZ L, SEPULVEDA MA, RUIZ-RIBO MD: Treatment of human brucellosis with netilmicin and doxycycline. Clin Infect Dis 1996; 22 (3): 441-5.
54. COHEN N, GOLIK A, ALON I, ZAIDENSTEIN R, DISHI V, KARPUCH J, ZYSSMAN I, MODAI D: Conservative treatment for Brucella endocarditis. Clin Cardiol 1997; 20 (3): 291-4.
55. VITAS AI, DIAZ R, GAMAZO C: Protective effect of liposomal gentamicin against systemic acute murine brucellosis. Chemotherapy 1997; 43: 204-10.
56. PRINTZIS S, RAPTOPOULOU-GIGI M, ORPHANOUKOUMERKERIDOU H, LAGRE F, GOULIS G: Immunotherapy in chronic brucellosis. Effect of levamisole and interferon; mechanisms of action and clinical value. Immunopharmacol Immunotoxicol 1994; 16 (4): 679-93.
57. JIMENEZ-DE-BAGUES MP, ELZER PH, JONES SM, BLASCO JM, ENRIGHT FM, SCHURIG GG, WINTER AJ: Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect Immun 1994; 62 (11): 4990-6.
58. OLIVEIRA SC, SPLITTER GA: Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 1996; 14 (10): 959-62.
59. CORBEL MJ: National Institute for Biological Standards and Control. Vaccines against bacterial zoonoses. Med Microbiol 1997; 46: 267-9.